Pune, India, January 2018 /MRFR Press Release/- Market Research Future has a cooked research report on the Global Glucose Tolerance Test market.
Market Research Future (MRFR)’s report highlights that the global glucose tolerance test market is poised to expand at a robust CAGR of 10.4% during the forecast period 2017 to 2023. High glucose level indicates the risk of diabetes which is responsible for a major proportion of deaths caused worldwide. In some cases, diabetes may even cause the organs of a body to fail prematurely. Millions of people are suffering from the disease and have to undergo regular checkups to keep the glucose levels under control. This, in turn, is projected to augment the glucose tolerance test market over the next couple of years.
The population of older adults is at a higher risk of developing diabetes. According to a statistical observation, the population of people over 60 years is likely to get doubled between 2015 and 2050. The growing alleged patient pool is fueling glucose tolerance test demand. In addition, diabetes is also passed on to the generations to come through genes. This is another major factor responsible for the expansion of the glucose tolerance test market. Furthermore, these tests are also being in excessive demand for the determination of the type of diabetes.
The market is likely to proliferate owing to the rising demand for the test of gestational diabetes. Key players and researchers are working on innovating new technologies and tests for improving the precision and efficiency of results. It is presumed to revolutionize the future trajectory of the glucose tolerance test market over the assessment period.
On the basis of products, the global glucose tolerance test market has been segmented into intramedullary Blood glucose testing kit (Lancet, Meters, Test strips and others), Smart sensors and others.
On the basis of indication, the glucose tolerance test market has been segmented into diabetes, gestational diabetes, insulin resistance, and reactive hypoglycemia.
On the basis of end user, the global glucose tolerance test market has been segmented into diagnostic clinics, hospitals, home, and others.
Some of the key players identified in this report are Panasonic, Abbott Laboratories, F. Hoffman-La Roche Ltd, Dexcom, Inc, LifeScan, Inc Sanofi, and Medtronic Plc.
The global glucose tolerance test market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is predicted to dominate a significant share of the global market. The food habits and busy lives of the population have led to a drastic rise in the diabetic population of the region. It has created much awareness among the patients which is prognosticated to emerge as the primary driving force of the glucose tolerance test market in the region.
Europe is an important growth pocket which is projected to witness significant growth owing to affordable access to standard healthcare facilities. The researches & developments supported by the governments are expected to boost the future trajectory of the glucose tolerance test market in the foreseeable future.
In January 2019, an oral glucose tolerance test (OGTT) has been developed by the Botnia Prospective Study. The test is claimed to improve the early prediction of type 2 diabetes.
In January 2019, researchers have established a link between maternal glucose with adverse perinatal outcomes under the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. The mothers, during the study, had a 75-g oral glucose tolerance test (OGTT).
In October 2018, researchers at the University of Missouri School of Medicine, and the Massachusetts Institute of Technology have developed a potential alternative to the finger prick test, that uses a process known as Raman spectroscopy, for evaluation of glucose levels.
Access Report Details @ https://www.marketresearchfuture.com/reports/glucose-tolerance-test-market-4921